🇯🇵·4d agoResearch
東北大学発スタートアップが 炎症性腸疾患の新薬開発を始動 ―患者由来オミクス研究を基盤とするMerak-Dubhe Therapeuticsが東北大学ベンチャーパートナーズによる資金調達―
Publisher
T
Tohoku University Hospital
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Tohoku University Hospital
- Region
- Japan
- Scope
- Research
- Published
- July 10, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on tohoku.ac.jp
Leave the platform to read the original full article on the publisher site.
Source: Tohoku University Hospital
Scope: Research
Related coverage
More related coverage
Universitätsklinikum Erlangen/3h ago
Die Kunst des „Im Wandel-Seins“
AACR/3h ago
Catching the Drift: How Wildfire Smoke Plumes May Increase Cancer Risk
University of Edinburgh/4h ago
Swimmer Archie Goodburn goes from graduation to the Games
European Molecular Biology Laboratory (EMBL)/5h ago